Benign Melanocytics Neoplasms


Benign Pigmented Cutaneous Lesions Other Than Melanocytic Nevi

  • This group of lesions can further be divided into: (1) predominantly epidermal lesions ( Table 92.1 ; Figs 92.1–92.5 ); and (2) dermal melanocytoses ( Table 92.2 ; Figs 92.6 and 92.7 ).

    Table 92.1
    Benign pigmented lesions other than melanocytic nevi (predominantly epidermal lesions).
    Lesion Major clinical features
    Ephelid (freckle)
    • Onset in childhood (UVR-induced) and tends to fade with age and in the absence of sun exposure (e.g. winter months)

    • Small, well-circumscribed, usually multiple, tan to brown macules on sun-exposed areas in fair-skinned individuals

    Lentigo simplex and mucosal melanotic lesions
    • Onset usually in childhood; not related to sun exposure

    • Small, sharply circumscribed, brown to black macule that can occur at any site, including mucosae; typically a few lesions

    • Multiple or generalized lentigines may be an isolated phenomenon or a marker of an underlying disorder ( Table 92.3 )

    • Onset in adulthood

    • Typically, an isolated to a few, brown to brown-black macule(s) on the vermilion portion of the lower lip (labial melanotic macules); occasionally on the gingiva, buccal mucosa, tongue, or palate ( Fig. 92.1 )

    • Multiple lesions (lentiginosis) may be a marker of Peutz–Jeghers or Laugier–Hunziker syndromes

    • Anogenital lentiginosis (anogenital melanotic macules) ( Fig. 92.2 )

    • Onset typically in adulthood; females > males

    • One or more brown to black macules, sometimes with irregular or jagged borders, mottled pigmentation, and occasionally of large size (>1 cm)

    • In females favors the labia minora > labia majora, vaginal introitus, perineum; in males favors the glans penis and penile shaft

    • Multiple lesions are a feature of lichen sclerosis, Laugier–Hunziker syndrome, and Bannayan–Riley–Ruvalcaba syndrome (see Table 52.1 )

    • Conjunctival melanosis (conjunctival melanotic macules)

    • Conjunctival brown to black pigmented macules, streaks, or patches

    • While congenital form is typically benign, primary acquired ocular melanosis is considered a precursor lesion of conjunctival melanoma

    Solar lentigo (lentigo senilis, “liver spot”)
    ( Fig. 92.3 )
    • Onset in adulthood (UVR-induced); persists throughout life and may darken with sun exposure, but does not fade

    • Typically, multiple tan to dark brown macules, often with irregular borders, ranging from a few millimeters to >1 cm in diameter

    • Distribution limited to sun-exposed sites, favoring those areas of greatest cumulative exposure (e.g. face, dorsal hands and forearms, upper trunk)

    • Clinical variants: ink spot lentigo, PUVA lentigo, tanning bed lentigo, sunburn lentigo

    • If present or widespread in young children, consider: xeroderma pigmentosum, type 2 oculocutaneous albinism (lesions are unusually large and jagged)

    Café-au-lait macule (CALM)
    ( Fig. 92.4 )
    • Onset at birth or in early childhood; not UVR-induced, but may first become noticeable following sun exposure

    • Uniformly colored, tan to brown macule or patch, varying in size from a few millimeters to >15 cm; grows proportionately with the child

    • Usually isolated but occasionally multiple; single CALM seen in ∼25–35% of children; <1% of children have ≥3 CALMs

    • Multiple CALMs may be associated with a variety of disorders (see Table 50.3 )

    Becker melanosis (nevus)
    ( Fig. 92.5 ; see Fig. 57.3 and Table 57.1 )
    • May be present at birth, but the majority appear around puberty; male:female ratio ∼5:1; stimulated by androgens

    • Classically, unilateral, tan to brown patch or thin plaque on the shoulder and/or upper trunk, but can occur elsewhere; margins typically irregular and break up into “islands” at the periphery; hypertrichosis in ∼50%

    • Associated smooth muscle hamartoma often present and is clinically apparent by the presence of perifollicular papules that are accentuated with rubbing

    • Infrequently associated with ipsilateral developmental anomalies (e.g. supernumerary nipples, breast hypoplasia, hypoplasia of the pectoralis major muscle, bony abnormalities)

    Fig. 92.1, Labial lentigines in a patient with Laugier–Hunziker syndrome.

    Fig. 92.2, Anogenital lentiginosis (anogenital melanotic macules).

    Fig. 92.3, Solar lentigines.

    Fig. 92.4, Café-au-lait macule (CALM).

    Fig. 92.5, Becker melanosis (nevus).

    Table 92.2
    The spectrum and clinical features of dermal melanocytoses.
    CALM, café-au-lait macule.
    Lesion Major clinical features
    Congenital dermal melanocytosis (Mongolian spots)
    ( Fig. 92.6 )
    • Typically apparent at birth or within the first few weeks of life

    • Regresses in >95% of patients by age 18 years; more likely to persist in extensive or extra-sacral variants; most common in Asians and Blacks

    • Presents as a single or multiple, uniform, blue-gray patch(es) with indefinite borders; favors the lumbosacral area and buttocks > back; varies in size from a few centimeters to >20 cm

    • CALM and melanocytic nevi that reside within these areas often have a “halo” that lacks dermal melanocytes ( Fig. 92.6 )

    • DDx: ecchymosis, child abuse, patch blue nevus, venous malformation

    • Extensive lesions may be associated with a port-wine stain (phakomatosis pigmentovascularis; see Ch. 85 ), developmental abnormalities (e.g. cleft lip), or inborn errors of metabolism (e.g. Hurler syndrome)

    Nevus of Ota , ∗∗ (oculodermal melanocytosis, nevus fuscocaeruleus ophthalmo-maxillaris) ( Fig. 92.7 )
    • Bimodal age of onset, with the majority (50–60%) present at birth or in infancy (before 1 year of age), and the remainder (40–50%) appearing at or around puberty; lifelong persistence

    • More common in Asians and Blacks; females > males

    • Involves those areas innervated by the first and second divisions of the trigeminal nerve, including the skin, conjunctiva, sclera, tympanic membrane, and/or oral and nasal mucosa; 10% of cases are bilateral

    • Lesions are characterized by speckled or mottled, grayish-brown to blue-black patches; may extend in size over time but usually stable by adulthood

    • Occasionally associated with neurocutaneous melanosis, glaucoma, ipsilateral sensorineural hearing loss, ocular melanoma (yearly ophthalmologic exams recommended)

    Nevus of Ito (nevus fuscocaeruleus acromiodeltoideus)
    • Favored populations and clinical appearance are similar to nevus of Ota (see above)

    • Involves areas of skin innervated by the posterior supraclavicular and lateral brachiocutaneous nerves, namely the supraclavicular, scapular, or deltoid regions; typically unilateral

    Nevus of Ota-like macules ∗∗ (acquired dermal melanocytosis, acquired bilateral nevus of Ota-like macules, Hori’s nevus)
    • Most often seen in middle-aged Asian females

    • Multiple grayish-brown macules arising in a symmetric, bilateral distribution on the malar cheeks and forehead and sometimes the eyelids, temple, and nose; does not involve mucosa

    • Important to distinguish from melasma, as laser therapy improves nevus of Ota-like macules

    DDx for nevus of Ota or Ito: patch or plaque blue nevus, ecchymosis, venous malformation; for nevus of Ito: extra-sacral Mongolian spot.

    ∗∗ Rx (if desired): pulsed Q-switched lasers (e.g. Q-switched ruby, alexandrite, or Nd:YAG lasers) beneficial but often requires multiple sessions.

    Fig. 92.6, Dermal melanocytosis (Mongolian spots) in a child with neurofibromatosis 1.

    Fig. 92.7, Nevus of Ota (oculodermal melanocytosis).

  • In the predominantly epidermal lesions, the tan to brown color can result from a variety of mechanisms – e.g. increased melanocyte activity (melanogenesis), increased melanin content in keratinocytes, and a mild increase in the number of melanocytes.

  • In dermal melanocytoses, the skin is blue to blue-gray in color (ceruloderma) due to the presence of melanin-producing melanocytes in the mid to lower dermis and the resultant Tyndall phenomenon (the preferential scattering of shorter wavelengths of light by the dermal melanin).

Acquired Melanocytic Nevi (Moles)

  • Benign proliferations of a type of melanocyte called a “nevus cell”.

  • Nevus cells differ from “ordinary” melanocytes, which typically reside as single units in the basal layer of the epidermis, in that they: (1) usually cluster as nests in the lower epidermis and/or dermis; and (2) do not have dendritic processes (except when found in a blue nevus).

  • Both “ordinary” melanocytes and nevus cells can produce melanin.

  • Acquired melanocytic nevi can be categorized as common (banal) or atypical (dysplastic), and they are further named based on the histopathologic location of the collections of nevus cells ( Fig. 92.8 ):

    • Junctional melanocytic nevus : dermal–epidermal junction

    • Compound melanocytic nevus: dermal–epidermal junction plus dermis

    • Intradermal melanocytic nevus: dermis

    Fig. 92.8, Three common types of acquired melanocytic nevi.

  • Variants include halo, blue, Spitz, and “special site” nevi ( Figs 92.9A–F and 92.10 ).

    Fig. 92.9, Variants of acquired melanocytic nevi.

  • Risk factors for developing acquired melanocytic nevi: (1) a family history of numerous nevi; (2) a greater degree of sun exposure during childhood, especially intermittent and intense; and (3) lightly pigmented skin (individuals with phototype II have the greatest number of nevi).

  • The vast majority of acquired melanocytic nevi remain as benign neoplasms throughout one’s life and do not require treatment.

  • Having numerous melanocytic nevi (>50–100) or multiple atypical nevi are phenotypic markers for an entire skin surface at risk for developing cutaneous melanoma; such persons should have lifelong surveillance with periodic total body skin examinations (beginning around puberty) and counseling regarding home self-skin examinations and sun protective measures.

  • Cutaneous melanoma may arise within a pre-existing nevus, but more than half of cutaneous melanomas arise de novo – i.e. in previously normal-appearing skin.

  • Most patients with numerous nevi and atypical nevi will have a prominent morphologic type of nevus (“signature nevus”); by recognizing signature nevi, the “ugly duckling” can be identified and closely examined.

  • Persons with more darkly pigmented skin will typically have darker colored nevi.

  • Rx: it is not necessary to remove clinically atypical nevi prophylactically in order to confirm the presence of histopathological atypia; biopsies of nevi are indicated primarily when a severely atypical nevus or cutaneous melanoma is in the DDx ( Table 92.4 ); if banal nevi become irritated (e.g. by clothing or jewelry), shave removal can be done.

  • When cutaneous melanoma is in the DDx , complete removal of the nevus is recommended as well as submission to a dermatopathologist; removal can be accomplished by several methods (see Fig. 1.6 ); providing additional information (e.g. eccentric hyperpigmented area) is also helpful.

Common (Banal) Acquired Melanocytic Nevi

  • Benign lesions with varied clinical appearance, but typically ≤6 mm in diameter, symmetric, well-circumscribed, evenly pigmented, and round or oval in shape; perifollicular hypopigmentation or stippled pigmentation is often present upon closer inspection.

  • Distribution favors intermittently sun-exposed areas of the trunk and extremities and, less frequently, acral sites (palms, soles, nail matrix); in patients who eventually develop many nevi, the scalp may be one of the first sites of involvement.

  • Classically appear after the first 6 months of life, increase in number during childhood and adolescence, peak by the third decade, and then slowly regress with age.

  • As nevi “age” over time, they often become more elevated, softer, and less pigmented.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here